{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:26:01Z","timestamp":1780514761198,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,12]]},"DOI":"10.7759\/cureus.106919","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T03:38:11Z","timestamp":1776051491000},"source":"Crossref","is-referenced-by-count":1,"title":["Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis Without Sodium-Glucose Cotransporter 2 Inhibitor Exposure: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Motaz","family":"Almahmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Abuafifeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Saied Sanosi","family":"Saied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayah","family":"Al Qaryoute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15749","article-title":"Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes","volume":"26 Suppl 3","author":"Silverii GA","year":"2024","unstructured":"Silverii GA. Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes. Diabetes Obes Metab. 2024, 26 Suppl 3:42-54. 10.1111\/dom.15749","journal-title":"Diabetes Obes Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i6.1178","article-title":"Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients","volume":"15","author":"See KC","year":"2024","unstructured":"See KC. Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients. World J Diabetes. 2024, 15:1178-86. 10.4239\/wjd.v15.i6.1178","journal-title":"World J Diabetes"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0032","article-title":"Hyperglycemic crises in adults with diabetes: A consensus report","volume":"47","author":"Umpierrez GE","year":"2024","unstructured":"Umpierrez GE, Davis GM, ElSayed NA, et al.. Hyperglycemic crises in adults with diabetes: A consensus report. Diabetes Care. 2024, 47:1257-75. 10.2337\/dci24-0032","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003666","article-title":"Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors","volume":"11","author":"Chow E","year":"2023","unstructured":"Chow E, Clement S, Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2023, 11:e003666. 10.1136\/bmjdrc-2023-003666","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning: Systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup","volume":"43","author":"Calello DP","year":"2015","unstructured":"Calello DP, Liu KD, Wiegand TJ, et al.. Extracorporeal treatment for metformin poisoning: Systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Crit Care Med. 2015, 43:1716-30. 10.1097\/CCM.0000000000001002","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.13113","article-title":"Metformin-associated lactic acidosis (MALA): Is it an underestimated entity? A retrospective, single-center case series","volume":"28","author":"Kim S","year":"2024","unstructured":"Kim S, Sarwal A, Yee XT, Fraga SA, Campion V, Gnanasekaran I. Metformin-associated lactic acidosis (MALA): Is it an underestimated entity? A retrospective, single-center case series. Hemodial Int. 2024, 28:32-9. 10.1111\/hdi.13113","journal-title":"Hemodial Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2586333","article-title":"Kidney replacement therapy and mortality in metformin-associated lactic acidosis with acute kidney injury (2015-2021): A multi-year cohort study","volume":"47","author":"Kananuruks S","year":"2025","unstructured":"Kananuruks S, Akkarakanoksin E, Panaput T, Faisatjatham S, Phisalwut S, Nongnuch A. Kidney replacement therapy and mortality in metformin-associated lactic acidosis with acute kidney injury (2015-2021): A multi-year cohort study. Ren Fail. 2025, 47:2586333. 10.1080\/0886022X.2025.2586333","journal-title":"Ren Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-017-1251-6","article-title":"Combined metformin-associated lactic acidosis and euglycemic ketoacidosis","volume":"129","author":"Schwetz V","year":"2017","unstructured":"Schwetz V, Eisner F, Schilcher G, et al.. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis. Wien Klin Wochenschr. 2017, 129:646-9. 10.1007\/s00508-017-1251-6","journal-title":"Wien Klin Wochenschr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-00761-2","article-title":"Metformin-associated lactic acidosis and euglycemic diabetic ketoacidosis: A case report","volume":"3","author":"Hasnie UA","year":"2021","unstructured":"Hasnie UA, Shen JZ, Hasnie AA, Tolwani A. Metformin-associated lactic acidosis and euglycemic diabetic ketoacidosis: A case report. SN Compr Clin Med. 2021, 3:698-700. 10.1007\/s42399-021-00761-2","journal-title":"SN Compr Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-023-00783-w","article-title":"Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose","volume":"12","author":"Kuno H","year":"2023","unstructured":"Kuno H, Fujimaru T, Kadota N, et al.. Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose. CEN Case Rep. 2023, 12:408-12. 10.1007\/s13730-023-00783-w","journal-title":"CEN Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000287","article-title":"Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure","volume":"12","author":"Nzomessi D","year":"2023","unstructured":"Nzomessi D, Massie E, Gariani K, Giraud R, Meyer P. Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure. Cardiovasc Endocrinol Metab. 2023, 12:e0287. 10.1097\/XCE.0000000000000287","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73708","article-title":"A rare case of metformin-induced lactic acidosis and concomitant euglycemic ketoacidosis","volume":"16","author":"Shiplett A","year":"2024","unstructured":"Shiplett A, Mathias J. A rare case of metformin-induced lactic acidosis and concomitant euglycemic ketoacidosis. Cureus. 2024, 16:e73708. 10.7759\/cureus.73708","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2025.02.018","article-title":"A case of concurrent metformin-associated lactic acidosis and euglycemic diabetic ketoacidosis","volume":"75","author":"Tomita D","year":"2025","unstructured":"Tomita D, Bamba Y, Kuwabara N, et al.. A case of concurrent metformin-associated lactic acidosis and euglycemic diabetic ketoacidosis. J Emerg Med. 2025, 75:222-6. 10.1016\/j.jemermed.2025.02.018","journal-title":"J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82717","article-title":"Life-threatening metformin-induced lactic acidosis associated with euglycemic ketoacidosis and acute multiorgan dysfunction: A case report","volume":"17","author":"Hussein KS","year":"2025","unstructured":"Hussein KS, Nadeem R, Nabil A. Life-threatening metformin-induced lactic acidosis associated with euglycemic ketoacidosis and acute multiorgan dysfunction: A case report. Cureus. 2025, 17:e82717. 10.7759\/cureus.82717","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95327","article-title":"Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome: A case report","volume":"17","author":"Almahmood M","year":"2025","unstructured":"Almahmood M, Saied A, Eltazi I, Al-Qudah BM, Alalawi A, Peediyakkal MZ, Nashwan AJ. Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome: A case report. Cureus. 2025, 17:e95327. 10.7759\/cureus.95327","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/ijciis.ijciis_46_23","article-title":"Metformin toxicity in the intensive care unit: A case series and review of the literature","volume":"14","author":"Peake KN","year":"2024","unstructured":"Peake KN, Tessier S, Longo S, Stahlnecker DM, Idahosa O, Zanders T, Ido F. Metformin toxicity in the intensive care unit: A case series and review of the literature. Int J Crit Illn Inj Sci. 2024, 14:51-8. 10.4103\/ijciis.ijciis_46_23","journal-title":"Int J Crit Illn Inj Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479497-concurrent-metformin-associated-lactic-acidosis-and-euglycemic-diabetic-ketoacidosis-without-sodium-glucose-cotransporter-2-inhibitor-exposure-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T03:38:26Z","timestamp":1776051506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479497-concurrent-metformin-associated-lactic-acidosis-and-euglycemic-diabetic-ketoacidosis-without-sodium-glucose-cotransporter-2-inhibitor-exposure-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.106919","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,12]]}}}